Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $87.80 Average PT from Brokerages
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation, five have given a buy recommendation and four […]
5 Apr 05:34 · The Markets Daily